These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19967778)

  • 1. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.
    Prodduturi S; Sadrieh N; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    J Pharm Sci; 2010 May; 99(5):2357-66. PubMed ID: 19967778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
    Marier JF; Lor M; Potvin D; Dimarco M; Morelli G; Saedder EA
    J Clin Pharmacol; 2006 Jun; 46(6):642-53. PubMed ID: 16707411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications.
    Sathyan G; Guo C; Sivakumar K; Gidwani S; Gupta S
    Curr Med Res Opin; 2005 Dec; 21(12):1961-8. PubMed ID: 16368047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transdermal delivery of fentanyl.
    Lane ME
    Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.
    Roy SD; Flynn GL
    Pharm Res; 1990 Aug; 7(8):842-7. PubMed ID: 1978306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch.
    Oliveira G; Hadgraft J; Lane ME
    Toxicol In Vitro; 2012 Jun; 26(4):645-8. PubMed ID: 22405881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
    Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
    AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation.
    Prodduturi S; Smith GJ; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    Pharm Res; 2009 Jun; 26(6):1344-52. PubMed ID: 19229594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Heat Effects on Fentanyl Transdermal Delivery Systems Using In Vitro Permeation and In Vitro Release Methods.
    Zhang Q; Murawsky M; LaCount TD; Hao J; Ghosh P; Raney SG; Kasting GB; Li SK
    J Pharm Sci; 2020 Oct; 109(10):3095-3104. PubMed ID: 32702372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic patches containing fentanyl: In vitro equivalence and abuse deterrent evaluation according to EMA and FDA guidelines.
    Padula C; Pescina S; Nicoli S; Santi P
    Int J Pharm; 2018 Feb; 537(1-2):57-63. PubMed ID: 29253583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
    Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
    J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerance of transdermal fentanyl administration in foals.
    Eberspächer E; Stanley SD; Rezende M; Steffey EP
    Vet Anaesth Analg; 2008 May; 35(3):249-55. PubMed ID: 18282254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent.
    Kress HG; Boss H; Delvin T; Lahu G; Lophaven S; Marx M; Skorjanec S; Wagner T
    Eur J Pharm Biopharm; 2010 Jun; 75(2):225-31. PubMed ID: 20152899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation.
    Marier JF; Lor M; Morin J; Roux L; Di Marco M; Morelli G; Saedder EA
    Br J Clin Pharmacol; 2007 Jan; 63(1):121-4. PubMed ID: 16939522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.